Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment

Area of Science:

• Oncology
• Nanomedicine
• Cancer Immunology

Background:

• The tumor microenvironment presents significant biological barriers (extracellular matrix, cellular components) and immunological challenges that impede effective cancer treatment.
• Cancer cells employ sophisticated mechanisms to evade immune surveillance, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the key components of the tumor biological and immunological microenvironment.
• To highlight recent advancements in nanoparticle-based drug delivery systems targeting the tumor microenvironment.
• To explore the potential of these systems in improving cancer chemotherapy and immunotherapy.

Main Methods:

• Literature review focusing on nanoparticle drug delivery systems.
• Analysis of strategies targeting biological barriers within the tumor microenvironment.
• Examination of nanoparticle applications in modulating anti-tumor immune responses.

Main Results:

• Nanoparticles can be engineered to navigate the extracellular matrix and cellular barriers.
• Nanoparticle drug delivery systems can enhance the efficacy of cancer immunotherapy by modulating immune cells like T cells, B cells, macrophages, and dendritic cells.
• Targeting the tumor microenvironment with nanoparticles shows potential for improving both chemotherapy and immunotherapy.

Conclusions:

• Understanding and targeting the tumor microenvironment is crucial for advancing cancer therapy.
• Nanoparticle-based drug delivery systems represent a versatile platform for overcoming treatment challenges in cancer.
• Further research into nanoparticle strategies holds significant promise for improving patient outcomes in cancer chemotherapy and immunotherapy.